Metraipolis › archive › dc_fed5c706ba36

Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey — Europe PMC PMID:42518363

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42518363
DOI
10.1016/j.obpill.2026.100298
License (as archived)
solo-consultazione
Archived
2026-10-18T09:37:49.772Z
SHA-256 of the archived text
87eb557d1f9df1e4dc95fb7e75e5adcab1c92506ef070feb455788e4e38e3d89
Stable URL of this page
https://metraipolis.com/documento/dc_fed5c706ba36

How to cite

Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey — Europe PMC PMID:42518363 — Europe PMC (en), https://europepmc.org/article/MED/42518363 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fed5c706ba36 (Metraipolis archive dc_fed5c706ba36, sha256 87eb557d1f9df1e4dc95fb7e75e5adcab1c92506ef070feb455788e4e38e3d89)
BibTeX
@misc{dcfed5c706ba36,
  title = {Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey — Europe PMC PMID:42518363},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42518363},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fed5c706ba36; sha256 87eb557d1f9df1e4dc95fb7e75e5adcab1c92506ef070feb455788e4e38e3d89},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518363. Agents can read the archived copy with the MCP tool read_document.